Apelian David 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Apelian David
Director
Transactions
- Award
Common Stock
2022-03-11+6,000→ 16,000 total - Award
Stock Option (Right to Buy)
2022-03-11+12,000→ 12,000 totalExercise: $5.10Exp: 2032-03-10→ Common Stock (12,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 11, 2022.
- [F2]The option vests in equal monthly installments over 12 months measured from March 11, 2022 subject to Reporting Person's continuous service status as of each such date.